These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 20851881

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Promotion of lipogenesis by PPARγ-activated FXR expression in adipocytes.
    Shinohara S, Fujimori K.
    Biochem Biophys Res Commun; 2020 Jun 18; 527(1):49-55. PubMed ID: 32446390
    [Abstract] [Full Text] [Related]

  • 24. Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis.
    Fiorucci S, Rizzo G, Antonelli E, Renga B, Mencarelli A, Riccardi L, Morelli A, Pruzanski M, Pellicciari R.
    J Pharmacol Exp Ther; 2005 Oct 18; 315(1):58-68. PubMed ID: 15980055
    [Abstract] [Full Text] [Related]

  • 25. De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis.
    Hamza MS, Pott S, Vega VB, Thomsen JS, Kandhadayar GS, Ng PW, Chiu KP, Pettersson S, Wei CL, Ruan Y, Liu ET.
    PLoS One; 2009 Oct 18; 4(3):e4907. PubMed ID: 19300518
    [Abstract] [Full Text] [Related]

  • 26. Antiatherosclerotic effect of farnesoid X receptor.
    Mencarelli A, Renga B, Distrutti E, Fiorucci S.
    Am J Physiol Heart Circ Physiol; 2009 Feb 18; 296(2):H272-81. PubMed ID: 19028791
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Adipocyte-specific expression of murine resistin is mediated by synergism between peroxisome proliferator-activated receptor gamma and CCAAT/enhancer-binding proteins.
    Tomaru T, Steger DJ, Lefterova MI, Schupp M, Lazar MA.
    J Biol Chem; 2009 Mar 06; 284(10):6116-25. PubMed ID: 19126543
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors.
    Singh R, Artaza JN, Taylor WE, Braga M, Yuan X, Gonzalez-Cadavid NF, Bhasin S.
    Endocrinology; 2006 Jan 06; 147(1):141-54. PubMed ID: 16210377
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis.
    Moldes M, Zuo Y, Morrison RF, Silva D, Park BH, Liu J, Farmer SR.
    Biochem J; 2003 Dec 15; 376(Pt 3):607-13. PubMed ID: 12954078
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Follistatin promotes adipocyte differentiation, browning, and energy metabolism.
    Braga M, Reddy ST, Vergnes L, Pervin S, Grijalva V, Stout D, David J, Li X, Tomasian V, Reid CB, Norris KC, Devaskar SU, Reue K, Singh R.
    J Lipid Res; 2014 Mar 15; 55(3):375-84. PubMed ID: 24443561
    [Abstract] [Full Text] [Related]

  • 38. The DLK gene is a transcriptional target of PPARγ.
    Couture JP, Blouin R.
    Biochem J; 2011 Aug 15; 438(1):93-101. PubMed ID: 21585338
    [Abstract] [Full Text] [Related]

  • 39. Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro.
    Phan J, Péterfy M, Reue K.
    J Biol Chem; 2004 Jul 09; 279(28):29558-64. PubMed ID: 15123608
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.